Author Guidelines

NEW - See Updated sections for the latest requirements.
 

1. SUMMARY OF SUBMISSION REQUIREMENTS

Thank you for your interest in The Journal of Dermatology. Please read the complete Author Guidelines carefully prior to submission, including the section on copyright and publication charges.
Once you have prepared your submission in accordance with the Guidelines, manuscripts should be submitted online at https://submission.wiley.com/journal/jde. For help with submissions, please contact: [email protected]
We look forward to your submission.

2. EDITORIAL CONSIDERATIONS

Aims and Scope

The Journal of Dermatology is the official peer-reviewed publication of the Japanese Dermatological Association and the Asian Dermatological Association. The journal aims to provide a forum for the exchange of information about new and significant research in dermatology and to promote the discipline of dermatology in Japan and throughout the world. Research articles are supplemented by reviews, theoretical articles, special features, commentaries, book reviews and proceedings of workshops and conferences. Preliminary or short reports and letters to the editor of two printed pages or less will be published as soon as possible. Papers in all fields of dermatology will be considered.

Editorial Review and Acceptance

The acceptance criteria for all papers are the quality and originality of the research and its significance to our readership. Except where otherwise stated, manuscripts are single-blind peer reviewed by two reviewers and the Editors. Papers will only be sent to review if the Editor-in-Chief determines that the paper meets the appropriate quality and relevance requirements. Final acceptance or rejection rests with the Editorial Board, who reserve the right to refuse any material for publication. Members of the Editorial Board who submit manuscripts to the journal are anonymised to the peer review process and excluded from editorial decision-making on their own work to minimise bias. Submission of a rejected manuscript by The Journal of Dermatology will not be considered.

Guidelines on Publishing and Research Ethics in Journal Articles

The journal requires that you include in the manuscript details IRB approvals, ethical treatment of human and animal research participants, and gathering of informed consent, as appropriate. You will be expected to declare all conflicts of interest, or none, on submission. Please review Wiley’s policies surrounding human studies, animal studies, clinical trial registration, biosecurity, and research reporting guidelines.

This journal follows the core practices of the Committee on Publication Ethics (COPE) and handles cases of research and publication misconduct accordingly (https://publicationethics.org/core-practices).

This journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read Wiley’s Top 10 Publishing Ethics Tips for Authors and Wiley’s Publication Ethics Guidelines.

Photographic Consents

A letter of consent must accompany all photographs of patients in which a possibility of identification exists. It is not sufficient to cover the eyes to mask identity.

Images and information from individual participants will only be published where the authors have obtained the individual's free prior informed consent. Patient anonymity should be preserved. Non-essential identifying details should be omitted.

Editors may request that reviewers comment on the standard of experimental reporting, experimental design, or any other aspects of the study reported that may cause concern. If concerns are raised or clarifications are needed, we may need to request evidence of ethical research approval.

Updated  Clinical Trials

The Journal of Dermatology requires that clinical trials are prospectively registered in one of the registries approved by ICMJE. The full name of the trial registry and the study clinical trial registration number must be included in the Ethics statement section of a manuscript (see section ‘Parts of the Manuscript’). A complete list of WHO Primary Registries that meet the requirements of ICMJE can be accessed here. If your trial is not registered, or was registered retrospectively, please explain the reasons for this in your cover letter.

Updated  Randomized Controlled Trials

Authors reporting randomized controlled trials are expected to follow the guidelines of the CONSORT Statement. The CONSORT Statement will also be used as the criteria of peer review for randomized controlled trial papers. The CONSORT flow diagram must also be included as a figure in the manuscript.
Please upload the Consort 2010 Checklist with your main text when you submit RCT manuscripts. Clinical trials must be registered prospectively before the recruitment of any participants..

Conflict of Interest

We require that all authors disclose any potential sources of conflict of interest. The existence of a conflict of interest does not preclude publication. A conflict of interest statement must be included within the manuscript (see section ‘Parts of the Manuscript’), and authors must also complete a Conflict of Interest form. Any interest or relationship, financial or otherwise that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript. Potential sources of conflict of interest include, but are not limited to, patent or stock ownership, membership of a company board of directors, membership of an advisory board or committee for a company, membership of The Journal of Dermatology editorial committee and consultancy for or receipt of speaker's fees from a company.

To download Conflict of Interest form, please click here. Completion the form is mandatory for all article categories.

Funding

Authors should list all funding sources in the Acknowledgments section. Authors are responsible for the accuracy of their funder designation. If in doubt, please check the Open Funder Registry for the correct nomenclature.

Authorship

The journal adheres to the definition of authorship set up by The International Committee of Medical Journal Editors (ICMJE). The ICMJE recommends that authorship be based on the following 4 criteria: i) Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; ii) Drafting the work or revising it critically for important intellectual content; iii) Final approval of the version to be published; and iv) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Contributors who do not qualify as authors should be mentioned under ‘Acknowledgements’.
In accordance with Wiley’s Best Practice Guidelines on Research Integrity and Publishing Ethics and the Committee on Publication Ethics’ guidance, The Journal of Dermatology will allow authors to correct authorship on a submitted, accepted, or published article if a valid reason exists to do so. All authors – including those to be added or removed – must agree to any proposed change. To request a change to the author list, please complete the Request for Changes to a Journal Article Author List Form and contact either the journal’s editorial or production office, depending on the status of the article. Authorship changes will not be considered without a fully completed Author Change form. [Correcting the authorship is different from changing an author’s name; the relevant policy for that can be found in Wiley’s Best Practice Guidelines under “Author name changes after publication.”]

ORCID

As part of our commitment to supporting authors at every step of the publishing process, the journal requires the submitting author (only) to provide an ORCID iD when submitting a manuscript.
This takes around 2 minutes to complete. Find more information.

COPE

This journal is a member of the Committee on Publication Ethics (COPE). Publication ethics guidelines can also be found at http://exchanges.wiley.com/ethicsguidelines.

Acceptable secondary publication

Secondary publication in the same or another language, especially in other countries, is justifiable and can be beneficial provided that the following conditions are met.

1. The authors have received approval from the editors of both journals; the editor concerned with secondary publication must have a photocopy, reprint, or manuscript of the primary version.
2. The priority of the primary publication is respected by a publication interval of at least 1 week (unless specifically negotiated otherwise by both editors).
3. The paper for secondary publication is intended for a different group of readers; an abbreviated version could be sufficient.
4. The secondary version faithfully reflects the authors, data and interpretations of the primary version.
5. The footnote on the title page of the secondary version informs readers, peers, and documenting agencies that the paper has been published in whole or in part and states the primary reference. A suitable footnote might read: “This is the secondary publication of the paper that was published in Vol. XX, Iss. X, pages XX - XX, doi:XXXXX of Journal XYZ. The authors have obtained permission for secondary publication from the Editor of Journal XYZ."

Please see here for further information.


3. MANUSCRIPT CATEGORIES AND REQUIREMENTS

Original Articles

Word limit: 6,000 words including abstract
Abstract: Unstructured (up to 300 words)
Figures/Tables: No limit
References: No limit
Description: Arrange text as follows: (i) title page, (ii) abstract and key words, (iii) text (divided into sections with the headings: Introduction, Methods, Results, Discussion), (iv) acknowledgments, (v) conflict of interest, (vi) references, (vii) supporting information, (viii) figure legends, (ix) tables (each table complete with title and footnotes) and (x) figures. Footnotes to the text are not allowed and any such material should be incorporated into the text as parenthetical matter.

Concise Communication

Word limit: 1,500 words including abstract
Abstract: Unstructured (up to 300 words)
Figures/Tables: Up to 3 (Multi panel figures must be compiled into one figure.)
References: Up to 15
Description: (a) A case report with mini review or with new observations of diseases, clinical findings or novel treatment outcomes; OR (b) a brief research paper. Arrange text as follows: (i) title page, (ii)abstract and key words, (iii) text (divided into sections with the headings: (a) Introduction, Case Report, Discussion or (b) Introduction, Methods, Results, Discussion) (iv)acknowledgments, (v) conflict of interest, (vi) references, (vii) supporting information, (viii) figure legends, (ix) tables (each table complete with title and footnotes) and (x) figures. Footnotes to the text are not allowed and any such material should be incorporated into the text as parenthetical matter.

Research Notes

Word limit: 750 words
Authors: Maximum 5 authors
Abstract: No abstract
References: Up to 7
Figures/ Tables: Up to 1 (Multi panel figures must be compiled into one figure. Additional tables/figures should be submitted as Supporting Information.)
Description: Research Notes are brief summary of interesting findings in basic research, reporting preliminary data relevant to the field. It should not include a detailed report or discussion but a concise and short description of the data and the findings.

Review Articles

Word limit: 5,000 words including abstract
Abstract: Unstructured (up to 300 words)
References: No limit
Figures/Tables: No limit. (Minimum 1 image or figure)
Description: Reviews are comprehensive analyses of specific topics. Both solicited and unsolicited review articles will undergo peer review prior to acceptance.

Images in Dermatology 

Word limit: 300 words
Authors: Maximum 5 authors
Abstract: No abstract
Figures/Tables: 1 image or figure (maximum of 4 panels for a composite image)
References: Up to 5
Keywords: 3 to 5 keywords
Description: Images in Dermatology consist of an image or figure of significant clinical interest or educational value. Include a concise description of the clinical issue and the key findings.

Letters to the Editor

Word limit: 500 words
Authors: Maximum ten authors
Abstract: No abstract
References: Up to 5
Figures/Tables: Up to 1 (Multi panel figures must be compiled into one figure.)
Description: The journal publishes two types of Letters to the Editor, listed below. Letters to the Editor of one printed pages or less will be published as soon as possible.
(i) Notes & Comments: Letters may be submitted to the Editor on any topic of discussion; clinical observations as well as letters commenting on papers published in recent issues.
(ii) Case Letters: Conclusions based on uncontrolled trials and/or limited experience should be stated in appropriately tentative terms. Concise descriptions detailing one or two patients, early reports of therapeutic trials in one or several patients, and early reports of new drug reactions.

Guidelines (Invited Only)

For secondary publications please refer to 'Acceptable secondary publication'.

Reporting Guidelines

Authors are encouraged to consult the reporting guideline that is most appropriate for their study design during the preparation of their manuscript (CONSORT, STROBE, PRISMA, ARRIVE, CARE etc.). Reporting guidelines can be accessed on the EQUATOR network website (http://www.equator-network.org/home/).

4. PREPARING THE MANUSCRIPT

Article Preparation Support

Wiley Editing Services offers expert help with English Language Editing, as well as translation, manuscript formatting, figure illustration, figure formatting, and graphical abstract design – so you can submit your manuscript with confidence. Also, check out our resources for Preparing Your Article for general guidance about writing and preparing your manuscript.

Writing for Search Engine Optimization

Optimize the search engine results for your paper, so people can find, read and ultimately cite your work. Simply read our best practice SEO tips – including information on making your title and abstract SEO-friendly, and choosing appropriate keywords. Click here for the 4 easy steps to SEO.

Preprint policy

Please find the Wiley preprint policy here. This journal accepts articles previously published on preprint servers.
The Journal of Dermatology will consider for review articles previously available as preprints. You may also post the submitted version of a manuscript to a preprint server at any time. You are requested to update any pre-publication versions with a link to the final published article.

Data Sharing and Data Availability

This journal encourages data sharing. Review Wiley’s Data Sharing policy where you will be able to see and select the data availability statement that is right for your submission.

Data Citation

Please review Wiley’s Data Citation policy.

Data Protection

By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, and other contact details the publication might require, will be used for the regular operations of the publication. Please review Wiley’s Data Protection Policy to learn more.

Manuscript Style

Manuscripts should follow the style of the Vancouver agreement detailed in the International Committee of Medical Journal Editors’ revised ‘Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication’, as presented at http://www.ICMJE.org.

Spelling: The journal uses US spelling and authors should therefore follow the latest edition of the Merriam-Webster’s Collegiate Dictionary.

Units: All measurements must be given in SI or SI-derived units. Please go to the Bureau International des Poids et Mesures (BIPM) website at https://www.bipm.org/en/about-us/ for more information about SI units.

Abbreviations: Abbreviations should be used sparingly -only where they ease the reader’s task by reducing repetition of long, technical terms. Initially use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation only.

Trade names: Drugs should be referred to by their generic names. If proprietary drugs have been used in the study, refer to these by their generic name, mentioning the proprietary name, and the name and location of the manufacturer, in parentheses.

Updated  Parts of the Manuscript

The length of manuscripts must adhere to the specifications under the section Manuscript Categories.
Manuscripts should be presented in the following order: (i) title page, (ii) abstract and key words, (iii) text, (iv) acknowledgments, (v) conflict of interest statement, (vi) ethics statement, (vii) references, (viii) figure legends, and (ix) tables (each table complete with title and footnotes). Figures and supporting information should be supplied in separate files.

Title page

The title page should contain:
(i) a short informative title that contains the major key words. The title should not contain abbreviations (see Wiley’s best practice SEO tips)
(ii) the names and institutional affiliations of all authors;
(iii) a short running title (no more than 40 characters, abbreviations are permitted)
The present address of any author, if different from that where the work was carried out, should be supplied in a footnote.

Abstract and key words

Original Articles, Concise Communication and Review Articles must have a brief abstract that states in 300 words the purpose, basic procedures, main findings and principal conclusions of the study. The abstract should not contain abbreviations or references.
Five key words, for the purposes of indexing, should be supplied below the abstract, in alphabetical order, and should be taken from those recommended by the US National Library of Medicine’s Medical Subject Headings (MeSH) browser list at http://www.nlm.nih.gov/mesh/meshhome.html.

Text

Authors should use the following subheadings to divide the sections of their manuscript: Introduction, Methods, Results and Discussion.

Acknowledgments

The source of financial grants and other funding must be acknowledged, including a frank declaration of the authors’ industrial links and affiliations. The contribution of colleagues or institutions should also be acknowledged. Personal thanks and thanks to anonymous reviewers are not appropriate.

Conflict of Interest Statement (applies to all article types)

In this section authors must describe any interest or relationship, financial or otherwise, that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript. Potential sources of conflict of interest include, but are not limited to, patent or stock ownership, any employment, leadership role or advisory role with a company, membership of The Journal of Dermatology editorial committee, and consultancy for or receipt of speaker's fees from a company. The absence of any interest to disclose must also be stated.

Please refer to the example conflict of interest statements below:

Multiple conflict of interests to declare:
Author A.T. has received a research grant from Company X. Author M.K. has received a speaker honorarium from Company Y. Author K.A. owns stock in Company Z. Author T.K. is the Editor-in-Chief of The Journal of Dermatology. Author Y.K. is an editorial board member of The Journal of Dermatology. To minimize bias, Authors Y.K. and T.K. were excluded from all editorial decision-making related to the acceptance of this article for publication.

No conflict of interests to declare:
Authors declare no conflict of interests for this article.

Updated Ethics statement

Authors must declare all information about ethics in this section including followings as appropriate:
 - Approval of the research protocol by an Institutional Reviewer Board.  If not applicable, please write N/A.
 - Informed Consent.  If not applicable, please write N/A.
 - Registry and the Registration No. of the study/trial.  If not applicable, please write N/A.
 - Animal Studies.  If not applicable, please write N/A.


References

References follow the Vancouver style, i.e. numbered sequentially as they occur in the text and ordered numerically in the reference list.

• All citations mentioned in the text, tables or figures must be listed in the reference list.
• If cited in tables or figure legends, number according to the first identification of the table or figure in the text.
• Reference to unpublished data and personal communications should not appear in the list but should be cited in the text only (e.g. Smith A, 2000, unpublished data).
• Authors are responsible for the accuracy of the references.
• Cite the names of all authors when there are six or fewer; when seven or more, list the first six followed by et al.

Journal Articles

When there are six or fewer authors, list all of them

Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347:284–7.

When there are more than seven authors, list the first six followed by et al.

O’Mahony S, Rose SL, Chilvers AJ, Ballinger JR, Solanki CK, Barber RW, et al. Finding an optimal method for imaging lymphatic vessels of the upper limb. Eur J Nucl Med Mol Imaging. 2004;31:555–63.

Journal article by DOI (before issue publication with no page numbers)

An online article that has not yet been published in an issue (therefore has no volume, issue or page numbers) can be cited by its Digital Object Identifier (DOI). The DOI will remain valid and allow an article to be tracked even after its allocation to an issue.

O'Mahony S, Rose SL, Chilvers AJ, Ballinger JR, Solanki CK, Barber RW, et al. Finding an optimal method for imaging lymphatic vessels of the upper limb. Eur J Nucl Med Mol Imaging. 2004. https://doi.org/10.1007/s00259-003-1399-3

Book

Murray PR, Rosenthal KS, Kobayashi GS, Pfaller MA. Medical microbiology. 4th ed. St. Louis: Mosby; 2002.

Chapter in a Book

Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations in human solid tumors. In: Vogelstein B, Kinzler KW, editors. The genetic basis of human cancer. New York: McGraw-Hill; 2002. p. 93–113.

Electronic Material

Abood S. Quality improvement initiative in nursing homes: the ANA acts in an advisory role. Am J Nurs [Internet]. 2002 Jun [cited 2002 Aug 12];102(6):[about 1 p.]. Available from: https://journals.lww.com/ajnonline/Fulltext/2002/06000/Quality_Improvement_Initiative_in_Nursing_Homes.31.aspx (Subscription required)

Tables

Tables should be self-contained and complement, but not duplicate, information contained in the text. They should be supplied as editable files, not pasted as images. Legends should be concise but comprehensive – the table, legend and footnotes must be understandable without reference to the text. All abbreviations must be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for P-values. Statistical measures such as SD or SEM should be identified in the headings.

Figure Legends

Legends should be concise but comprehensive – the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement. Figure legends should be included within the main text document.

Preparing Figures

Although we encourage authors to send us the highest-quality figures possible, for peer-review purposes we are happy to accept a wide variety of formats, sizes, and resolutions.
Click here for the basic figure requirements for figures submitted with manuscripts for initial peer review, as well as the more detailed post-acceptance figure requirements.
Multi panel figures must be compiled into one figure for Concise Communication, Research Notes and Letters to the Editor.

Color figures: Figures submitted in color may be reproduced in color online and in print free of charge, if they are of sufficient quality. Please note, however, that it is preferable that line figures (eg graphs and charts) and supplied in black and white so that they are legible if printed by a reader in black and white.

Supporting Information

Supporting information is hosted online separately to the article. This should be used for information that is not essential to the article but that provides greater depth and background. It may include tables, figures, videos, datasets, etc. This material can be submitted with your manuscript, and will appear online, without editing or typesetting. Guidelines on how to prepare this material and which formats and files sizes are acceptable can be found at: http://exchanges.wiley.com/authors/supporting-information-guide_336.html
Please note that the provision of supporting information is not encouraged as a general rule. It will be assessed critically by reviewers and editors and will only be accepted if it is essential.

Reproduction of Copyright Material

If excerpts from copyrighted works owned by third parties are included, credit must be shown in the contribution. It is authors’ responsibility to also obtain written permission for reproduction from the copyright owners. For more information visit Wiley’s Copyright Terms & Conditions FAQ.
The corresponding author is responsible for obtaining written permission to reproduce the material "in print and other media" from the publisher of the original source, and for supplying Wiley with that permission upon submission.

5. SUBMISSION OF MANUSCRIPTS

New submissions should be made via the Research Exchange submission portal https://submission.wiley.com/journal/jde. Should your manuscript proceed to the revision stage, you will be directed to make your revisions via the same submission portal. You may check the status of your submission at anytime by logging on to submission.wiley.com and clicking the “My Submissions” button. For technical help with the submission system, please review our FAQs or contact [email protected].

Manuscripts can be uploaded either as a single document (containing the main text, tables and figures), or with figures and tables provided as separate files. Should your manuscript reach revision stage, figures and tables must be provided as separate files. The main manuscript file can be submitted in Microsoft Word (.doc or .docx) format.

Your main document file should include:

• A short informative title containing the major key words. The title should not contain abbreviations
• The full names of the authors with institutional affiliations where the work was conducted, with a footnote for the author’s present address if different from where the work was conducted;
• Acknowledgments;
• Abstract (unstructured)
• Up to five keywords;
• Main body: formatted as Introduction, Methods, Results, and Discussion.
• References;
• Tables (each table complete with title and footnotes);
• Figures: Figure legends must be added beneath each individual image during upload AND as a complete list in the text.

• Cover letter  can be uploaded to the ‘Cover letter / Comments’ section as optional. Submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium. This must be stated in the covering letter. Also contain an acknowledgment that all authors have contributed significantly, and that all authors are in agreement with the content of the manuscript. In keeping with the latest guidelines of the International Committee of Medical Journal Editors, each author’s contribution to the paper is to be quantified. If tables or figures have been reproduced from another source, state that you obtained a written permission for reproduction from the copyright owners to reproduce the material.
• At revision stage, each figure should be supplied as a separate file, with the figure number incorporated in the fi le name. Multi-panel figures (figures with parts a, b, c, d, etc.) should be submitted as a single file that contains all parts of the figure. For submission, low-resolution figures saved as .jpg or .bmp files should be uploaded, for ease of transmission during the review process. Upon acceptance of the article, high-resolution figures (at least 300 d.p.i.) saved as .eps or .tif files should be uploaded. Digital images supplied as low-resolution PowerPoint files or PDFs cannot be used.
• Author material archive policy, authors who require the return of any submitted material that is accepted for publication should inform the Editorial Office after acceptance. If no indication is given that author material should be returned, Wiley will dispose of all hardcopy and electronic material two months after publication.

6. COPYRIGHT, LICENSING AND OPEN ACCESS

Accepted papers will be passed to Wiley’s production team for publication. The author identified as the formal corresponding author for the paper will receive an email prompting them to login into Wiley’s Author Services, where via the Wiley Author Licensing Service (WALS) they will be asked to complete an electronic license agreement on behalf of all authors on the paper.
Authors may choose to publish under the terms of the journal’s standard copyright transfer agreement (CTA), or under Open Access under the terms of a Creative Commons License. Note that certain funders mandate a particular type of CC license be used. This journal uses the CC-BY/CC-BY-NC/CC-BY-NC-ND Creative Commons License.

Standard Copyright Transfer Agreement: FAQs about the terms and conditions of the standard CTA in place for the journal, including standard terms regarding archiving of the accepted version of the paper, are available at: Copyright Terms and Conditions FAQs.
Note that in signing the journal’s licence agreement authors agree that consent to reproduce figures from another source has been obtained.

Open Access Option: Authors will have the option to choose to make your article open access after acceptance, which will be subject to an APC.

For more information on this journal’s APCs, please see the Open Access page.

Self-Archiving Definitions and Policies: Note that the journal’s standard copyright agreement allows for self-archiving of different versions of the article under specific conditions.

7. PUBLICATION PROCESS AFTER ACCEPTANCE

Wiley Author Services: Tracking your article’s progress

Author Services enables authors to track their article throughout the production process to publication. Authors can check the status of their articles online and choose to receive automated e-mails at key stages of production. The corresponding author will receive a unique link that enables them to register and have their article automatically added to the system. Please ensure that a complete e-mail address is provided when submitting the manuscript. Visit https://authorservices.wiley.com/author-resources/Journal-Authors/Publication/index.html for more details on online production tracking.

Proofing

The corresponding author will receive an e-mail alert containing a link to their PDF article proof as well as details on how to provide proof corrections. It is therefore essential that a working e-mail address be provided for the corresponding author. Note that proofs should be returned 48 hours from receipt of first proof. Please note that the author is responsible for all statements made in their work, including changes made during the editorial process and thus you must check your proofs carefully.

Publication Charges

There is a publication charge of ¥20,000/US$200 per printed page. A form requesting payment will be available for download with your PDF proof. The publication charge for Letter to the Editor and Images in Dermatology is ¥20,000/US$200 per article.

Early View

The journal offers rapid speed to publication via Wiley’s Early View service. Early View articles are complete full-text articles published online in advance of their publication in an issue. Early View articles are complete and final. They have been fully reviewed, revised and edited for publication, and the authors' final corrections have been incorporated. Because they are in final form, no changes can be made after online publication. Early View articles are given a Digital Object Identifier (DOI), which allows the article to be cited and tracked before allocation to an issue. After issue publication, the DOI remains valid and can continue to be used to cite and access the article.

8. POST PUBLICATION

Article PDF for authors

A PDF of the published article will be made available to the authors free of charge via Author Services.

Printed Offprints

Printed offprints may be ordered online for a fee. Please click on the following link and fill in the necessary details and ensure that you type information in all of the required fields: https://www.sheridan.com/wiley/eoc

Promoting Your Work

Wiley’s worldwide network and deep collection of content allows us to promote articles published on Wiley Online Library far and wide. We also invest heavily in search engine optimization and usability to ensure the widest possible visibility of the articles we publish. We make it easy for readers to find, read and cite your work.
You can also help increase the impact of your work by promoting your article yourself. The Wiley Author Promotional Toolkit provides you with information on how to use social media, publicity, conferences, multimedia, email and the web to promote your article.

Article Promotion Support

Wiley Editing Services offers professional video, design, and writing services to create shareable video abstracts, infographics, conference posters, lay summaries, and research news stories for your research – so you can help your research get the attention it deserves.

Measuring the Impact of your Work

Wiley also helps you measure the impact of your research through our specialist partnerships with Kudos and Altmetric.

Author Name Change policy

In cases where authors wish to change their name following publication, Wiley will update and republish the paper and redeliver the updated metadata to indexing services. Our editorial and production teams will use discretion in recognizing that name changes may be of a sensitive and private nature for various reasons including (but not limited to) alignment with gender identity, or as a result of marriage, divorce, or religious conversion. Accordingly, to protect the author’s privacy, we will not publish a correction notice to the paper, and we will not notify co-authors of the change. Authors should contact the journal’s Editorial Office with their name change request.

9. CONTACT

Editorial Office of The Journal of Dermatology 
c/o Wiley Publishing Japan K.K.
Nomura Fudosan Nishi Shinjuku Bldg. 8F
8-4-2 Nishi Shinjuku Shinjuku-ku, Tokyo
160-0023 Japan
Email: [email protected]
Tel: +81 3 4520 9055

Author Guidelines updated October 2024